What are Gyre Therapeutics, Inc.'s profit margins?

Gyre Therapeutics, Inc. (GYRE) runs a 95.1% gross margin and a -0.1% operating margin, with a 6.3% net margin.

Where do Gyre Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Gyre Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Gyre Therapeutics, Inc. GYRE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	95.1%-1.1pp	95.4%-1.0pp	95.5%-0.8pp	95.9%—	96.2%—
Operating margin	-0.1%-10.4pp	9.9%-5.4pp	11.2%+83.7pp	9.1%—	10.3%—
EBITDA margin	2.1%-9.8pp	12%-4.8pp	13.4%+84.5pp	11.2%—	12%—
Returns
Return on invested capital	-0.1%—	12.8%—	——	——	——
Efficiency
Asset turnover	0.8×0.0×	0.8×-0.1×	0.8×-0.8×	0.7×—	0.8×—
Inventory turnover	0.6×—	0.7×—	0.6×—	——	——
Liquidity
Current ratio	4.6×+1.0×	5.6×+2.3×	6.2×+2.5×	5.4×+2.0×	3.6×+0.4×
Quick ratio	4.1×+0.9×	5×+2.0×	5.6×+2.3×	4.9×+1.8×	3.2×+0.2×
Cash ratio	1.9×+1.1×	2×+1.4×	2.5×+1.5×	2.2×+1.1×	0.8×-0.7×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×—	0×—	0×—
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×—	0×—
Net debt / EBITDA	-14.8×—	-2.6×—	-2.7×—	——	——
Per Share
Book value per share	$1.11+66.0%	$1.03+66.0%	$0.98+59.3%	$0.90+51.8%	$0.67+21.0%
Valuation
Market capitalization	$694.58M-4.7%	$680.11M-34.5%	$677.57M-42.2%	$689.9M-32.4%	$722.69M-51.6%
Enterprise value	$657.9M-8.0%	$643.98M-37.4%	$638.33M-44.9%	$654.8M—	$709.23M—
Price / sales	5.9×-1.3×	5.8×-4.0×	6.3×-4.8×	6.8×—	7.2×—
Price / book	6.9×-3.8×	6.4×-10.0×	6.6×—	7.5×—	10.6×—
EV / EBITDA	265.6×+206×	46.1×—	44.6×—	——	——
EV / sales	5.6×-1.5×	5.5×-4.2×	6×-5.1×	6.4×—	7×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Gyre Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Gyre Therapeutics, Inc.'s profit margins?: Gyre Therapeutics, Inc. (GYRE) runs a 95.1% gross margin and a -0.1% operating margin, with a 6.3% net margin.
Where do Gyre Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Gyre Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.